A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
Related Research units
Bibliographical data
| Original language | German |
|---|---|
| Article number | 4 |
| ISSN | 0887-6924 |
| Publication status | Published - 2008 |
| pubmed | 17851552 |
|---|
